Eurofins Pharma Bioanalytical Services announces new consulting services
Eurofins Pharma Bioanalytical Services has launched a consulting program to support clients conducting large molecule preclinical and clinical studies.
The large molecule-focused bioanalytical and biomarker contract research organization (CRO) has facilities in Oxford, UK and St. Charles, US.
The company develops, transfers, and validates large molecule PK, ADA and biomarker assays and offers various pre-qualified assays.
According to the company, the Eurofins Pharma Bioanalytical Services consulting program will provide guidance on bioanalytical assay development and assay validation.
Eurofins Bioanalytical Services did not respond to a request for comment.
